Telmisartan Betere antihypertensive Ho sireletsa renal

Tšireletso ea methapo ea pelo le ea boko:

Telmisartan e hlahella e le eona feela sethethefatsi se kang sartan se amohetsoeng ke FDA bakeng sa thepa ea eona ea ts'ireletso ea pelo le cerebrovascular. E bontša bokhoni ba ho khutlisa hypertrophy ea ventricular e ka morao 'me e khothalletsoa bakuli ba nang le khatello ea kelello e tsamaeang le le letšehali ventricular hypertrophy, ho se sebetse ha pelo, kapa lefu la methapo ea mali. Ntle le litlamorao tsa eona tsa ho theola khatello ea mali, Telmisartan e fokotsa tšenyo ea pelo le methapo ea mali. E bohlokoa haholo ho batho ba nang le stroke kapa infarction ea pelo.

Ho sireletsa mosebetsi oa renal:

Molemo o mong oa Telmisartan ke phello e ntle mosebetsing oa renal. Kaha Telmisartan e kena metabolism ea sebete 'me e ntšoa ka bile, e na le phello e fokolang mosebetsing oa renal. Ho feta moo, Telmisartan e fumanoe e fokotsa proteinuria, ka hona e sireletsa ts'ebetso ea renal. E bohlokoa haholo ho bakuli ba nang le khatello ea mali le maemo a comorbid joalo ka nephropathy ea lefu la tsoekere, microalbuminuria, proteinuria, kapa ho se sebetse hantle hoa renal ha bobebe ho isa bohareng.

Ho ntlafatsa ho hanyetsa insulin:

Telmisartan e bonts'itse litlamorao tse ntle ho metabolism ea tsoekere le ho hanyetsa insulin. Tšobotsi ena e etsa hore e be khetho e nepahetseng bakeng sa bakuli ba nang le khatello ea mali le lefu la tsoekere, kaha e ka thusa ho ntlafatsa kutloisiso ea insulin le taolo ea tsoekere.